Antitumor metal compounds: more than theme and variations, Dalton Trans, pp.183-194, 2008. ,
The resurgence of platinum-based cancer chemotherapy, Nat. Rev. Cancer, vol.7, pp.573-584, 2007. ,
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity, Coord. Chem. Rev, vol.249, pp.2845-2853, 2005. ,
Challenges and Opportunities in the Development of Organometallic Anticancer Drugs, Organometallics, vol.31, pp.5677-5685, 2012. ,
Exploration of the medical periodic table: towards new targets, Chem. Commun, pp.49-5106, 2013. ,
Administration of substances to laboratory animals: routes of administration and factors to consider, J. Am. Assoc. Lab. Anim. Sci, vol.50, pp.600-613, 2011. ,
The status of platinum anticancer drugs in the clinic and in clinical trials, Dalton Trans, pp.39-8113, 2010. ,
Understanding and Improving Platinum Anticancer Drugs ? Phenanthriplatin, Anticancer Res, vol.34, pp.471-476, 2014. ,
Complexes of palladium(II), platinum(II), copper(II), cobalt(II), and zinc(II) chlorides with 6,6?-dimethyl-2,2?-dipyridyl, J. Inorg. Nucl. Chem, vol.43, pp.1529-1531, 1981. ,
Incorporation of new amphiphilic perfluoroalkylated bipyridine platinum and palladium complexes into liposomes: stability and structure-incorporation relationships, Biochim. Biophys. Acta, pp.41-48, 1127. ,
Synthesis and characterization of amphiphilic platinum and palladium complexes linked to perfluoroalkylated side-chain disubstituted bipyridines, Inorg. Chim. Acta, vol.194, pp.247-253, 1992. ,
In vitro and in vivo studies of neutral cyclometallated complexes against murine leukaemias, Can. J. Chem, vol.83, pp.980-989, 2005. ,
Effect of charge and surface area on the cytotoxicity of cationic metallointercalation reagents, Can. J. Chem, vol.83, pp.969-979, 2005. ,
Novel 4,4?-diether-2,2?-bipyridine cisplatin analogues are more effective than cisplatin at inducing apoptosis in cancer cell lines, Bioorg. Med. Chem, vol.18, pp.1163-1170, 2010. ,
A fluorine containing bipyridine cisplatin analog is more effective than cisplatin at inducing apoptosis in cancer cell lines, Bioorg. Med. Chem, vol.14, pp.8692-8700, 2006. ,
Cytotoxic activity of new amphiphilic perfluoroalkylated bipyridine platinum and palladium complexes incorporated into liposomes, Eur. J. Med. Chem, vol.28, pp.235-242, 1993. ,
DNA Binding to an Anticancer Organo-Ruthenium Complex, J. Phys. Chem. B, pp.114-14041, 2010. ,
Cancer Cell Cytotoxicity of Cyclometalated Compounds Obtained with Osmium(II) Complexes, Inorg. Chem, vol.52, pp.2705-2715, 2013. ,
The Most Widely Used Ligand. A Review of Molecules Comprising at Least Two 2,2?-Bipyridine Units, Chem. Rev, vol.100, pp.3553-3590, 2000. ,
Cyclometalation of 2,2?-Bipyridine. Mono-and Dinuclear C,N Platinum(II) Derivatives, Organometallics, vol.28, pp.2150-2159, 2009. ,
Palladium(II) and platinum(II)-C(3)-substituted 2,2?-bipyridines, Chem. Heterocycl. Compd, vol.35, pp.992-1000, 1999. ,
Activation of a C-H Bond in a Pyridine Ring. Reaction of 6-Substituted 2,2?-Bipyridines with Methyl and Phenyl Platinum(II) Derivatives: N?,C(3)-?Rollover? Cyclometalation, Organometallics, vol.22, pp.4770-4777, 2003. ,
Intramolecular C(sp2)-H Bond Activation in 6,6?-Dimethoxy-2,2?-Bipyridine with Gold(III). Crystal and Molecular Structure of the First N?,C(3) ?Rollover? Cycloaurated Derivative, Organometallics, vol.29, pp.1064-1066, 2010. ,
, Organometallics, vol.31, pp.2971-2977, 2012.
Mesoionic Complexes of Platinum(II) Derived from ?Rollover? Cyclometalation: A Delicate Balance between Pt-C(sp3) and Pt-C(sp2) Bond Cleavage as a Result of Different Reaction Conditions, Organometallics, vol.32, pp.438-448, 2013. ,
Rollover Cyclometalation with 2-(2?-Pyridyl)quinoline, Inorg. Chem, vol.52, pp.7717-7731, 2013. ,
Assembly of symmetrical and unsymmetrical platinum(II) rollover complexes with bidentate phosphine ligands, Dalton Trans, vol.43, pp.14806-14815, 2014. ,
Synthesis, biological evaluation, and molecular docking studies on the DNA binding interactions of platinum(II) rollover complexes containing phosphorus donor ligands, 817?828. (29), vol.34, pp.456-465, 2015. ,
Synthesis, characterization and antitumor activity study of some cyclometalated organoplatinum(II) complexes containing aromatic Ndonor ligands, J. Organomet. Chem, vol.696, pp.3135-3142, 2011. ,
Cyclometalated platinum(II) complexes comprising 2-(diphenylphosphino)pyridine and various thiolate ligands: synthesis, spectroscopic characterization, and biological activity, Eur. J. Inorg. Chem, 2017. ,
Cyclometalated platinum(II) complexes containing monodentate phosphines: antiproliferative study, J. Iran. Chem. Soc, vol.11, pp.1207-1216, 2014. ,
Platinum (II) complex with cyclometalating 2-phenylpyridine ligand showing high cytotoxicity against cisplatin-resistant cell, J. Inorg. Biochem, vol.84, pp.157-158, 2001. ,
Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance, J. Med. Chem, vol.44, pp.4661-4667, 2001. ,
Cyclometalated Platinum(II) Complexes Bearing Bidentate O,O?-Di(alkyl)-dithiophosphate Ligands: Photoluminescence and Cytotoxic Properties, Organometallics, vol.36, pp.1707-1717, 2017. ,
Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties, J. Med. Chem, vol.58, pp.5825-5841, 2015. ,
New Palladium(II) and Platinum(II) Complexes with the Model Nucleobase 1-Methylcytosine: Antitumor Activity and Interactions with DNA, Inorg. Chem, vol.44, pp.7365-7376, 2005. ,
, A. New Palladium(II) and Platinum(II) Complexes with 9-Aminoacridine: Structures, Luminescence, Theoretical Calculations, and Antitumor Activity, vol.47, pp.6990-7001, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01469439
Novel C,N-chelate platinum(II) antitumor complexes bearing a lipophilic ethisterone pendant, J. Inorg. Biochem, vol.105, pp.525-531, 2011. ,
Acetonimine and 4-Imino-2-methylpentan-2-amino Platinum(II) Complexes: Synthesis and in Vitro Antitumor Activity, Inorg. Chem, vol.47, pp.10025-10036, 2008. ,
A bifunctional platinum(II) complex capable of intercalation and hydrogen-bonding interactions with DNA: Binding studies and cytotoxicity, Coord. Chem. Rev, vol.9, issue.42, pp.84-95, 2003. ,
In Vitro and In Vivo Antitumor Activities and DNA Binding Mode of Five Coordinated Cyclometalated Organoplatinum(II) Complexes Containing Biphosphine Ligands, J. Med. Chem, vol.54, pp.6166-6176, 2011. ,
Cytotoxicity of cyclometalated platinum complexes based on tridentate NCN and CNN-coordinating ligands: Remarkable coordination dependence, J. Inorg. Biochem, vol.134, pp.49-56, 2014. ,
Synthesis of a monophosphorus analog of hexamethylenetetramine, J. Heterocycl. Chem, vol.11, pp.407-408, 1974. ,
2?:6?,2?-Terpyridine)-methylplatinum(II) chloride and (1,10-phenanthroline)-methylchloroplatinum(II), vol.2 ,
, Organic Chemistry Basic Laboratory Course, vol.880, p.pp, 1977.
Route of absorption of intraperitoneally administered compounds, J. Pharmacol. Exp. Ther, vol.178, pp.562-566, 1971. ,
Binding of cis-and trans-dichlorodiammineplatinum(II) to DNA: Evidence for unwinding and shortening of the double helix, Science, vol.203, pp.1014-1016, 1979. ,
Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin, Nature, vol.377, pp.649-652, 1995. ,
Solution structure of a cisplatin-induced DNA interstrand cross-link, Science, vol.270, pp.1842-1845, 1995. ,
Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands, Mol. Pharmacol, vol.71, pp.357-365, 2007. ,
Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?, Chem. Rev, vol.99, pp.2499-2510, 1999. ,
Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action, Cancer Res, vol.52, pp.5065-5072, 1992. ,
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination, Gynecol. Oncol, vol.127, pp.241-248, 2012. ,
Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells, J. Anal. At. Spectrom, pp.51-61, 2009. ,
decane): a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells, Chem. Commun, pp.1396-1397, 2001. ,
Observations on the mechanism of halogen-bridge cleavage by unidentate ligands in square planar palladium and platinum complexes, Aust. J. Chem, vol.47, pp.217-227, 1994. ,
Rollover-Assisted C(sp2)-C(sp3) Bond Formation, Chem. -Eur. J, vol.20, pp.5501-5510, 2014. ,
Crystal structure of dichloro(N-methyl-2,2?-bipyridylium)platinum(II), C 11 H 10 Cl 2 N 2 Pt, Z. Kristallogr, pp.148-150, 0198. ,
Metal-based drugs that break the rules, Dalton Trans, vol.45, pp.3201-3209, 2016. ,
Cellular interactions of platinum drugs, Inorg. Chim. Acta, vol.393, pp.75-83, 2012. ,
Anticancer metallodrug research analytically painting the ?omics? picture-current developments and future trends, Anal. Bioanal. Chem, pp.405-1791, 2013. ,
Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: Relevance to antitumor activity, J. Inorg. Biochem, vol.102, pp.2136-2141, 2008. ,
Fragmentation methods on the balance: unambiguous top-down mass spectrometric characterization of oxaliplatin-ubiquitin binding sites, Anal. Bioanal. Chem, vol.402, pp.2655-2662, 2012. ,
Am(m)ines Make the Difference: Organoruthenium Am(m)ine Complexes and Their Chemistry in Anticancer Drug Development, Chem. -Eur. J, vol.19, pp.4308-4318, 2013. ,
Biomolecule binding vs. anticancer activity: Reactions of Ru(arene)[(thio)pyr(id)one] compounds with amino acids and proteins, J. Inorg. Biochem, vol.108, pp.91-95, 2012. ,
Phase I trial of a cisplatinalbumin complex for the treatment of cancer of the head and neck, Br. J. Clin. Pharmacol, vol.33, 1992. ,
, Inorg. Chem, vol.57, pp.2851-2864, 2018.
Plasmids as test system for the detection of DNA strand breaks, NATO ASI Ser., Ser. A, vol.243, pp.49-52, 1993. ,
Synthesis and Antiproliferative Activity of a C,N-Cycloplatinated(II) Complex with a Potentially Intercalative Anthraquinone Pendant, Inorg. Chem, vol.50, 2011. ,
ROS-mediated cytotoxic effect of copper(II) hydrazone complexes against human glioma cells, Molecules, vol.19, pp.17202-17220, 2014. ,
, DNA interactions of antitumor trans
, Eur. J. Biochem, vol.254, pp.547-557, 1998.
Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis, Cell Death Differ, vol.14, 2007. ,
A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin, Oncotarget, vol.8, pp.2568-2584, 2017. ,
Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63. eLife 2016, 5, e10528. (76) Cubillos-Ruiz, J. R, vol.168, pp.692-706, 2017. ,
Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistance, Chem. Sci, vol.7, pp.4117-4124, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02365338
Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes, Angew. Chem., Int. Ed, vol.54, pp.6483-6487, 2015. ,
E platinum, a newly synthesized platinum compound, induces apoptosis through ROS-triggered ER stress in gastric carcinoma cells, Mol. Carcinog, vol.56, pp.218-231, 2017. ,
Luminescent organoplatinum(II) complexes containing bis(N-heterocyclic carbene) ligands selectively target the endoplasmic reticulum and induce potent photo-toxicity, Chem. Commun, vol.49, pp.5423-5425, 2013. ,
ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis, Curr. Mol. Med, vol.9, pp.411-416, 2009. ,
Translational regulator eIF2? in tumor, Tumor Biol, vol.35, pp.6255-6264, 2014. ,